Miguel Zubizarreta, CEO, and Robert Arch, President of Immunophotonics, Inc., are preparing to share key company updates and growth milestones at the LSX Investival Showcase USA, taking place March 10–11, 2026, at the Miami Beach Convention Center.

Catch their presentation:  March 10 | 12:00 PM at the Biotech Growth Stage

Miguel and Robert will highlight Immunophotonics’ pioneering efforts in Interventional Immuno-Oncology®, with a focus on our lead molecule, IP-001. This novel approach is designed to stimulate anti-tumor immune responses following injection after routine local tumor ablation therapies and prevent cancer from coming back – one of the most critical unmet needs in cancer care: preventing recurrence.